A. Moffat

Effectiveness at 1 Year of Monthly versus Variable-Dosing Intravitreal Ranibizumab in the Treatment of Choroidal Neovascularization Secondary to Age-related Macular Degeneration

S. Boyd, A. Berger, Rajeev H. Muni, 2012, Retina.